Scholarlink

Purpose <p>This study aimed to evaluate medication adherence among patients with chronic uveitis using the five-item Medication Adherence Report Scale (MARS-5) and to identify the difficulties and barriers affecting adherence.</p> Methods <p>A single-center, cross-sectional study was conducted with 99 adult patients diagnosed with chronic uveitis. Participants completed sociodemographic and disease-related questionnaires, the MARS-5 scale, and if scoring below 25 a nine-item adherence barrier questionnaire. Descriptive statistics and appropriate parametric or non-parametric tests were used to analyze relationships between adherence and sociodemographic or clinical variables.</p> Results <p>The mean age of the participants was 32.6 ± 8.7 years, and the mean total MARS-5 score was 22.9 ± 2.3. Adherence levels were perfect in 38.4% of patients, high in 48.5%, and moderate in 13.1%; no participants demonstrated poor adherence. Male patients exhibited significantly lower MARS-5 scores than females (<i>p</i><i> &lt; 0.001</i>). A moderate positive correlation was found between adherence and duration of medication use (<i>r</i><i> = 0.447</i>, <i>p</i><i> = 0.012</i>). The item most frequently indicating non-adherence was “forgetting to take medication.” The most commonly reported barriers were fear of side effects (34.4%) and medication-related difficulties such as unpleasant taste, tablet size, or injection-related concerns (26.2%).</p> Conclusion <p>Medication adherence among chronic uveitis patients was generally high but influenced by sociodemographic and behavioral factors. Both intentional and unintentional non-adherence were observed, emphasizing the need for individualized adherence-support strategies, improved patient education, and enhanced communication to optimize long-term disease management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Treatment adherence in chronic uveitis: What does the MARS-5 tell us?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月2日

查看全文
  • Mehtap Caglayan,
  • Dilbade Yıldız Ekinci,
  • Betül Dertsiz Kozan

摘要

Purpose

This study aimed to evaluate medication adherence among patients with chronic uveitis using the five-item Medication Adherence Report Scale (MARS-5) and to identify the difficulties and barriers affecting adherence.

Methods

A single-center, cross-sectional study was conducted with 99 adult patients diagnosed with chronic uveitis. Participants completed sociodemographic and disease-related questionnaires, the MARS-5 scale, and if scoring below 25 a nine-item adherence barrier questionnaire. Descriptive statistics and appropriate parametric or non-parametric tests were used to analyze relationships between adherence and sociodemographic or clinical variables.

Results

The mean age of the participants was 32.6 ± 8.7 years, and the mean total MARS-5 score was 22.9 ± 2.3. Adherence levels were perfect in 38.4% of patients, high in 48.5%, and moderate in 13.1%; no participants demonstrated poor adherence. Male patients exhibited significantly lower MARS-5 scores than females (p < 0.001). A moderate positive correlation was found between adherence and duration of medication use (r = 0.447, p = 0.012). The item most frequently indicating non-adherence was “forgetting to take medication.” The most commonly reported barriers were fear of side effects (34.4%) and medication-related difficulties such as unpleasant taste, tablet size, or injection-related concerns (26.2%).

Conclusion

Medication adherence among chronic uveitis patients was generally high but influenced by sociodemographic and behavioral factors. Both intentional and unintentional non-adherence were observed, emphasizing the need for individualized adherence-support strategies, improved patient education, and enhanced communication to optimize long-term disease management.